Latest Quarter
Q2 FY2026ended 2026-06-30 · filed 2026-08-06
$210.75M
$65.84M
$121.72M
$9.38
$205.21M
$964.63M
$394.32M
$31.11M
What this quarter tells us
For Q1 FY2026 ended March 31, 2026, Nutex Health reported revenue of $216.5 million, up 2.2% year-over-year. Net income surged to $46.8 million from $21.2 million in the prior year, a 120.6% increase. Operating income was $81.3 million, and diluted EPS was $6.52, up 95.8%. The company held $207.3 million in cash, $346.3 million in equity, and $24.3 million in long-term debt.
- •Revenue increased 2.2% YoY to $216.5 million.
- •Net income rose 120.6% YoY to $46.8 million.
- •Diluted EPS grew 95.8% to $6.52.
- •Cash and equity stood at $207.3 million and $346.3 million, respectively.
Informational summary based on SEC XBRL figures · generated by deepseek-v4-flash. Not investment advice.